Suppr超能文献

区分哮喘、慢性支气管炎和肺气肿。

Distinguishing among asthma, chronic bronchitis, and emphysema.

作者信息

Snider G L

出版信息

Chest. 1985 Jan;87(1 Suppl):35S-39S. doi: 10.1378/chest.87.1.35s.

Abstract

The history holds the central role in distinguishing among asthma, chronic bronchitis, and emphysema. A personal or family history of atopy, a history of seasonal worsening of disease in response to a known environmental agent, perhaps seasonal, and marked variability in the severity of airflow obstruction, often with dramatic responsiveness to bronchodilator drugs, strongly support the diagnosis of asthma. Exacerbation of wheezing by exposure to cold air or following the ingestion of a drug, and asthma variants, such as nocturnal cough responsive to bronchodilator agents or exercise-induced asthma, all support the diagnosis of asthma. Peripheral blood eosinophilia or sputum eosinophilia support the diagnosis of asthma providing other known causes of eosinophilia can be excluded. Positive skin tests are helpful in establishing the atopic state and indicating its possible etiology. An elevated serum IgE level supports the diagnosis of asthma; a normal one does not exclude it. Cigarette smoking is a common background factor in both chronic bronchitis and emphysema, and both diseases are infrequently observed in the absence of this history. Long-standing mucous hypersecretion preceding airflow obstruction suggests the presence of chronic bronchitis. Progressive dyspnea on effort as the predominant symptom suggests the possibility of emphysema. Reversibility of airflow obstruction suggesting the presence of asthma can be obtained either from physical examination or serial pulmonary function studies. Apart from this, neither of these techniques is very useful in differential diagnosis. Evidence of emphysema in the chest roentgenogram and a low value of the Dco/VA are sensitive tests for the presence of emphysema but are not highly specific. The main value of making the differentiation among these three conditions now lies in establishing a prognosis and guiding the use of corticosteroid therapy. As new information accumulates on the pathogenesis, prevention, and treatment of asthma, chronic bronchitis, and emphysema, precise diagnosis is likely to acquire increased significance.

摘要

病史在区分哮喘、慢性支气管炎和肺气肿方面起着核心作用。个人或家族过敏史、疾病因已知环境因素(可能是季节性的)而出现季节性加重、气流阻塞严重程度有显著变异性且常对支气管扩张剂药物有显著反应,这些都强烈支持哮喘的诊断。接触冷空气或摄入药物后喘息加重以及哮喘变异型,如对支气管扩张剂有反应的夜间咳嗽或运动性哮喘,均支持哮喘的诊断。外周血嗜酸性粒细胞增多或痰液嗜酸性粒细胞增多支持哮喘的诊断,前提是能排除其他已知的嗜酸性粒细胞增多原因。阳性皮肤试验有助于确定过敏状态并提示其可能的病因。血清IgE水平升高支持哮喘的诊断;正常水平不能排除哮喘。吸烟是慢性支气管炎和肺气肿常见的共同背景因素,若无此病史,这两种疾病都很少见。气流阻塞前长期存在黏液分泌亢进提示慢性支气管炎。以进行性劳力性呼吸困难为主要症状提示肺气肿的可能性。气流阻塞的可逆性提示哮喘的存在,可通过体格检查或系列肺功能研究获得。除此之外,这些技术在鉴别诊断中都不太有用。胸部X线片上肺气肿的证据以及Dco/VA值降低是诊断肺气肿的敏感试验,但特异性不高。区分这三种情况的主要价值目前在于确定预后并指导皮质类固醇治疗的使用。随着关于哮喘、慢性支气管炎和肺气肿的发病机制、预防和治疗的新信息不断积累,精确诊断可能会变得越来越重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验